Page 54 - Product Testing News Today

Press release content from Business Wire. The AP news staff was not involved in its creation. New Nondestructive Testing Equipment Market Research During 2021-2025 | Post-pandemic Industry Planning Structure | Technavio January 21, 2021 GMT Technavio has announced its latest market research report titled Global Nondestructive Testing (NDT) Equipment Market 2021-2025 (Graphic: Business Wire) Technavio has announced its latest market research report titled Global Nondestructive Testing (NDT) Equi...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Pfizer and BioNTech Publish Results of Study Showing COVID-19 Vaccine Elicits Antibodies that ... BioNTech SEJanuary 20, 2021 GMT New York and Mainz, Germany, January 20, 2021 — Today, Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced results from an in vitro study that provides additional data on the capability of sera from individuals immunized with the Pfizer-BioNTech COVID-19 vac...

Press release content from Business Wire. The AP news staff was not involved in its creation. Merck Announces U.S. FDA Approval of VERQUVO® (vericiguat) January 20, 2021 GMT KENILWORTH, N.J.--(BUSINESS WIRE)--Jan 20, 2021-- Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved VERQUVO, a soluble guanylate cyclase (sGC) stimulator, to reduce the risk of cardiovascular death and heart failure hospitaliza...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Orchard Therapeutics Secures Partnerships to Broaden Access to LibmeldyTM for Eligible Patients ... Orchard Therapeutics (Europe) LimitedJanuary 19, 2021 GMT BOSTON and LONDON, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced plans to extend the company’s commercial reach in the Middle East and Turkey through exclusive agreements...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Global WholeHealth Partners Corp (GWHP-OTC) to Announce that the Antibody Test Kits Offered by ... Global WholeHealth Partners Corp.January 20, 2021 GMT Global’s Antibody Test Can Detect the New CoViD 19 SARS 2 Strain SAN CLEMENTE, CA, Jan. 20, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Charles Strongo, CEO of Global WholeHealth Partners Corp (GWHP-OTC), comments on https://www.cbsnews.com/news/co...

Press release content from Business Wire. The AP news staff was not involved in its creation. ENHERTU® Approved in the EU for the Treatment of HER2 Positive Metastatic Breast Cancer January 20, 2021 GMT Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca’s ENHERTU ® (trastuzumab deruxtecan) has been granted conditional approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive breast cancer...

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Press release content from Accesswire. The AP news staff was not involved in its creation. Theralase Launches Second Clinical Study Site in the US for Phase II Bladder Cancer Clinical Study January 20, 2021 GMT TORONTO, ON / ACCESSWIRE / January 20, 2021 / Theralase® Technologies Inc. (“Theralase” or “Company”) (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and development of light activated Photo Dynamic Compounds (“PDC”) and their associa...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. PharmaTher Signs Exclusive Worldwide License Agreement for Patented Ketamine Formulation ... Newscope Capital CorporationJanuary 19, 2021 GMT TORONTO, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Newscope Capital Corporation (CSE: PHRM) (OTCQB: PHRRF), who through its wholly-owned subsidiary, PharmaTher Inc. (“PharmaTher”), is a specialty life sciences company focused on the research and development of psych...

Press release content from PR Newswire. The AP news staff was not involved in its creation. OncoSec Medical Announces Proposed Public Offering of Common Stock January 20, 2021 GMT OncoSec Medical Incorporated logo (PRNewsfoto/OncoSec Medical Incorporated) PENNINGTON, N.J. and SAN DIEGO, Jan. 20, 2021 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ:ONCS) (the “Company” or “OncoSec”), a late-stage biotechnology company focused on designing, developing and commercializing innovative t...